Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 37,550 KRW
Change Today +1,350 / 3.73%
Volume 335.6K
096530 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:28 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for seegene inc (096530)

Although debt as a percent of total capital decreased at Seegene, Inc. over the last fiscal year to 24.45%, it is still in-line with the Biotechnology industry's norm. Additionally, there are enough liquid assets to satisfy current obligations.
View Balance Sheet In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2010
Press
Release

KRW
Dec 31
2011
Press
Release

KRW
Dec 31
2012
Press
Release

KRW
Dec 31
2014
KRW
4 Year
Trend
Assets    
Cash and Equivalents--18,372.64,306.119,530.6
Short-Term Investments--15,936.98,133.79,086.7
Trading Asset Securities------2,513.0
TOTAL CASH AND SHORT TERM INVESTMENTS19,536.434,309.612,439.831,130.4
Accounts Receivable--24,351.233,161.550,051.8
Other Receivables------520.4
TOTAL RECEIVABLES--24,351.233,161.550,572.2
Inventory--2,670.64,727.312,219.4
Prepaid Expenses------318.8
Other Current Assets--1,556.72,290.03,002.5
TOTAL CURRENT ASSETS--62,888.152,618.697,243.4
Gross Property Plant and Equipment------19,074.5
Accumulated Depreciation-------9,116.6
NET PROPERTY PLANT AND EQUIPMENT--2,809.24,479.19,957.9
Goodwill------1,253.2
Long-Term Investments--2,000.02,618.81,634.0
Accounts Receivable, Long Term--4,048.28,971.0755.4
Loans Receivable, Long Term------1,457.7
Deferred Tax Assets, Long Term--768.81,854.82,872.7
Deferred Charges, Long Term------16,400.9
Other Intangibles--5,973.613,073.4903.3
Other Long-Term Assets------5,974.9
TOTAL ASSETS--78,487.883,615.6138,453.3
    
LIABILITIES & EQUITY    
Accounts Payable--4,534.35,068.64,122.8
Accrued Expenses------865.9
Short-Term Borrowings------4,057.9
Current Portion of Long-Term Debt/Capital Lease------118.3
Current Income Taxes Payable--1,034.42,077.91,070.1
Other Current Liabilities, Total--569.6168.92,219.3
TOTAL CURRENT LIABILITIES--6,138.27,315.412,454.3
Long-Term Debt--30,194.031,422.826,521.0
Minority Interest------84.8
Pension & Other Post-Retirement Benefits--1,423.42,827.24,527.4
Other Non-Current Liabilities----113.0115.7
TOTAL LIABILITIES--37,755.541,678.443,618.4
Common Stock--6,536.36,548.112,652.6
Additional Paid in Capital--23,158.023,169.751,932.4
Retained Earnings--10,889.119,516.538,395.6
Treasury Stock-------8,224.2
Comprehensive Income and Other--148.9-7,297.0-6.4
TOTAL COMMON EQUITY30,236.340,732.341,937.294,750.1
TOTAL EQUITY30,236.340,732.341,937.294,834.9
TOTAL LIABILITIES AND EQUITY--78,487.883,615.6138,453.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
096530:KS 37,550.00 KRW +1,350

096530 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cepheid $55.65 USD -1.46
GenMark Diagnostics Inc $10.86 USD -2.02
Luminex Corp $16.29 USD -0.24
QIAGEN NV €23.06 EUR -0.57
Sequenom Inc $4.28 USD -0.06
View Industry Companies
 

Industry Analysis

096530

Industry Average

Valuation 096530 Industry Range
Price/Earnings 100.0x
Price/Sales 14.7x
Price/Book 10.0x
Price/Cash Flow 70.4x
TEV/Sales 13.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEEGENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.